AAPL 170.33 +0.29 (+0.17%)MSFT 108.2 +0.55 (+0.51%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 170.33 +0.29 (+0.17%)MSFT 108.2 +0.55 (+0.51%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Financial Summary GTXI Quote GTx Inc.

GTx Inc. Quote

GTx Inc. (GTXI)

0.96 -0.01 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D
Symbol GTXI
Price 0.96
Beta 1.54
Vol Avg 119.86 K
Mkt cap 423.33 M
Shares 17
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -107.14% Strong Sell
ROA -61.86% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity 21.05% Neutral
P/E -0.54
P/B 0.43 Neutral
Company Profile

CEO

Marc S. Hanover

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Capital Market

Description

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.